Table 1.
Patients with narcolepsy type 1
| Subject | Sex | Age (y) | Duration (y) | Medication |
|---|---|---|---|---|
| 1 | F | 31 | 3 | Mo, SSRI |
| 2 | F | 40 | 5 | Mo, Me |
| 3 | F | 27 | 3 | — |
| 4 | M | 23 | 1 | Mo |
| 5 | M | 51 | 16 | Mo |
| 6 | F | 23 | 9 | S |
| 7 | F | 23 | 9 | Me |
| 8 | F | 35 | 3 | S, SNRI |
| 9 | F | 20 | 2 | Me, S |
| 10¤ | M | 27 | 0 | — |
| 11 | F | 34 | 6 | — |
| 12 | M | 24 | 4 | Mo |
| 13 | F | 23 | 7 | Mo, Me |
| 14 | F | 20 | 7 | Me |
| 15 | F | 28 | 8 | Me, S |
| 16 | F | 21 | 2 | Mo, SNRI |
| 17 | M | 19 | 4 | Mo |
| 18 | M | 46 | 4 | Mo, S, SNRI |
| 19 | M | 17 | 7 | Me |
| 20¤ | M | 17 | 8 | Me |
| 21 | M | 33 | 4 | — |
| 22 | M | 32 | 0 | Mo |
| 23 | M | 21 | 8 | Me, S |
Notes: F = female, M = male, ¤ = excluded for motion, Mo = modafinil, Me = methylphenidate, S = sodium oxybate, SSRI = selective serotonin reuptake inhibitor, SNRI = Serotonin–norepinephrine reuptake inhibitor, Age (y) = age in years at time of imaging, Duration (y) = disease duration in years at time of imaging.